Coldstream Capital Management Inc Arcutis Biotherapeutics, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,169 shares of ARQT stock, worth $33,424. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,169Holding current value
$33,424% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARQT
# of Institutions
245Shares Held
129MCall Options Held
2.06MPut Options Held
168K-
Suvretta Capital Management, LLC New York, NY11.4MShares$176 Million6.61% of portfolio
-
Jennison Associates LLC11.4MShares$175 Million0.13% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$169 Million4.91% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$135 Million7.34% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$133 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $927M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...